癌症治疗口服药物的依从性和持久性观点。
Perspectives on adherence and persistence with oral medications for cancer treatment.
机构信息
Novartis, East Hanover, NJ.
出版信息
J Oncol Pract. 2011 Jan;7(1):65-7. doi: 10.1200/JOP.2010.000076.
Abstract
Ensuring persistence, continuing treatment for the prescribed duration, and adherence-taking medication as prescribed-have been challenges for management of patients with oral cancer and for health care cost containment in real-world settings.
摘要
确保患者的持续性治疗，即按照规定的疗程继续治疗，以及坚持用药（即按照规定服药），这是口腔癌患者管理和控制实际医疗成本方面所面临的挑战。
相似文献
1
Perspectives on adherence and persistence with oral medications for cancer treatment.
J Oncol Pract. 2011 Jan;7(1):65-7. doi: 10.1200/JOP.2010.000076.
2
Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review.
BMJ Open. 2019 Apr 14;9(4):e027049. doi: 10.1136/bmjopen-2018-027049.
3
Methotrexate and injectable tumor necrosis factor-α inhibitor adherence and persistence in children with rheumatic diseases.
J Rheumatol. 2013 Jan;40(1):80-6. doi: 10.3899/jrheum.120753. Epub 2012 Nov 1.
4
A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
Front Pharmacol. 2019 Jan 29;9:1567. doi: 10.3389/fphar.2018.01567. eCollection 2018.
5
Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial.
JMIR Res Protoc. 2014 Dec 23;3(4):e79. doi: 10.2196/resprot.4041.
6
Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care.
Adv Ther. 2019 Nov;36(11):3110-3122. doi: 10.1007/s12325-019-01098-y. Epub 2019 Sep 26.
7
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
JAMA Cardiol. 2020 Jan 1;5(1):38-46. doi: 10.1001/jamacardio.2019.4408.
8
Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
Pharmacotherapy. 2017 Oct;37(10):1221-1230. doi: 10.1002/phar.1989. Epub 2017 Sep 6.
9
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis.
BMC Musculoskelet Disord. 2017 Apr 11;18(1):152. doi: 10.1186/s12891-017-1514-4.
10
Medication Persistence, Duration of Treatment, and Treatment-switching Patterns Among Canadian Patients Taking Once-daily Extended-release Methylphenidate Medications for Attention-Deficit/Hyperactivity Disorder: A Population-based Retrospective Cohort Study.
Clin Ther. 2016 Aug;38(8):1789-802. doi: 10.1016/j.clinthera.2016.07.001. Epub 2016 Jul 29.
引用本文的文献
1
Optimizing Adherence to Oral Anticancer Agents: Results from an Implementation Mapping Study.
Curr Oncol. 2025 Jan 29;32(2):78. doi: 10.3390/curroncol32020078.
2
Impact of Patient Personality on Adherence to Oral Anticancer Medications: An Opportunity?
JMIR Cancer. 2024 Oct 30;10:e57199. doi: 10.2196/57199.
3
Association between adherence with oral anticancer medications and short-term health care resource utilization: A 2010-2018 claims-based analysis.
J Manag Care Spec Pharm. 2024 Apr;30(4):326-335. doi: 10.18553/jmcp.2024.23134. Epub 2024 Jan 19.
4
Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized Trial.
Cancers (Basel). 2020 Sep 8;12(9):2550. doi: 10.3390/cancers12092550.
5
High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis.
Clin Infect Dis. 2021 Apr 26;72(8):1350-1357. doi: 10.1093/cid/ciaa222.
6
High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany.
Support Care Cancer. 2019 Nov;27(11):4265-4271. doi: 10.1007/s00520-019-04721-4. Epub 2019 Mar 11.
7
Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.
Pharmacy (Basel). 2018 Mar 8;6(1):23. doi: 10.3390/pharmacy6010023.
8
The Effect of Structured Education to Patients Receiving Oral Agents for Cancer Treatment on Medication Adherence and Self-efficacy.
Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):290-298. doi: 10.4103/apjon.apjon_35_17.
9
Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore.
Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):283-289. doi: 10.4103/2347-5625.212864.
10
Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors.
Med Oncol. 2017 Jun;34(6):104. doi: 10.1007/s12032-017-0958-6. Epub 2017 Apr 25.
本文引用的文献
1
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
J Clin Oncol. 2010 Sep 20;28(27):4120-8. doi: 10.1200/JCO.2009.25.9655. Epub 2010 Jun 28.
2
Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.
J Clin Oncol. 2010 May 10;28(14):2418-22. doi: 10.1200/JCO.2009.26.4671. Epub 2010 Apr 5.
3
Comparing adherence and persistence across 6 chronic medication classes.
J Manag Care Pharm. 2009 Nov-Dec;15(9):728-40. doi: 10.18553/jmcp.2009.15.9.728.
4
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients.
Curr Med Res Opin. 2010 Jan;26(1):61-9. doi: 10.1185/03007990903396469.
5
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.
Blood. 2009 May 28;113(22):5401-11. doi: 10.1182/blood-2008-12-196543. Epub 2009 Apr 6.
6
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
Breast Cancer Res Treat. 2009 Oct;117(3):615-23. doi: 10.1007/s10549-009-0366-5. Epub 2009 Mar 18.
7
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
Ann Oncol. 2009 Mar;20(3):431-6. doi: 10.1093/annonc/mdn646. Epub 2009 Jan 15.
8
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.
Br J Cancer. 2008 Dec 2;99(11):1763-8. doi: 10.1038/sj.bjc.6604758. Epub 2008 Nov 4.
9
NCCN Task Force Report: Oral chemotherapy.
J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1-14.
10
Medication compliance and persistence: terminology and definitions.
Value Health. 2008 Jan-Feb;11(1):44-7. doi: 10.1111/j.1524-4733.2007.00213.x.
Zotero 插件